A study assessing the steady-state pharmacokinetics and Ctrough of erlotinib over a long time period in patients with pancreatic cancer.
Phase of Trial: Phase IV
Latest Information Update: 16 Oct 2016
At a glance
- Drugs Erlotinib (Primary)
- Indications Pancreatic cancer
- Focus Pharmacokinetics
- 16 Oct 2016 New trial record